Pharmalot... Pharmalittle... The Weekend Nears

And so, another working week will soon draw to a close. This is, as you know, our treasured signal to daydream about weekend plans. Our agenda is somewhat uncertain at the moment, although there is a soccer match involving one of the short people. We also hope to tidy up around the mansion and, perhaps, catch up with some old friends. And you? Anything interesting planned? If the weather is accommodating, this may be an opportunity to enjoy the great outdoors. Or maybe plan a trip to Portland, Maine, to enjoy the new recreational law. You could also contemplate the future of your health insurance. Whatever you do, have a grand time, but be safe. See you soon... FDA Raises Safety Concerns Over Sanofi MS Drug Lemtrada (Reuters) Salix Pharmaceuticals To Buy Santarus For $2.6 Billion (Bloomberg News) Ariad Cuts 40 Percent Of Workforce After Cancer Drug Failure (Xconomy) EMA Questions AstraZeneca Over Brilinta Clinical Trial (Reuters) New Roche Leukemia Drug Shows Advantage Over Rituxan In Study (Reuters) Sanofi To Manufacture Orexigen Therapeutics Diet Drug (Contract Pharma) Arena Expands Deal With Eisai To Market Diet Drug (Bloomberg News) EDITOR'S NOTE:...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs